EAP30 Activators
EAP30 Activators consist of a group of chemical compounds that, through various mechanisms, enhance the functional activity of EAP30, a component of the ESCRT-II complex critical for endosomal sorting. Forskolin, which raises cAMP levels, indirectly activates EAP30 by promoting PKA activity, which may lead to phosphorylation events that enhance EAP30's role in vesicular trafficking. Similarly, the polyphenol EGCG, by inhibiting multiple kinases, could redirect signaling towards pathways where EAP30 is functionally required, thus enhancing its activity in endocytic processes. The PI3K inhibitors, LY294002 and Wortmannin, by modifying endocytic trafficking, augment the function of EAP30 through altered lipid kinase signaling. Thapsigargin and the calcium ionophores, Ionomycin and A23187, increase intracellular calcium levels, which may influence EAP30's role in the formation and sorting of multivesicular bodies (MVBs).
Additionally, the direct PKC activator PMA and the tyrosine kinase inhibitor Genistein may elevate EAP30's functional activity by influencingthe ESCRT-II complex's role in vesicle formation and trafficking. PMA, by stimulating PKC, could potentiate EAP30's involvement in the regulation of endosomal sorting. In contrast, Genistein's inhibition of tyrosine kinases might reduce competitive signaling, favoring the activation of pathways where EAP30 is essential. Sphingosine-1-phosphate (S1P) operates through G-protein coupled receptors and may enhance EAP30's activity by modulating endocytic trafficking, a process in which EAP30 plays a pivotal part. Further, the kinase inhibitor Staurosporine could selectively amplify EAP30-mediated pathways by inhibiting kinases that negatively regulate the ESCRT-II complex, suggesting a refined enhancement of EAP30's function in endosomal sorting. Collectively, these EAP30 Activators, through targeted effects on cellular signaling, facilitate the enhancement of EAP30's role in the crucial cellular process of endocytic trafficking without altering its expression levels or direct activation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC), which is involved in various signaling pathways including those that regulate the assembly and function of the ESCRT-II complex, to which EAP30 belongs. Activation of PKC may enhance the functionality of EAP30 in endosomal sorting. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which can lead to the activation of PKA. PKA phosphorylation can modulate trafficking and sorting processes where EAP30 is a critical component, thus enhancing its function. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin acts as a calcium ionophore, increasing intracellular calcium concentration. Elevated calcium levels can influence vesicle trafficking, a process in which EAP30 is implicated, thereby potentially enhancing its function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has been shown to inhibit various protein kinases, potentially shifting signaling pathways to favor those that require EAP30's involvement in endocytic sorting and trafficking, thereby enhancing its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which may result in altered endocytic trafficking. Since EAP30 is part of the ESCRT-II complex involved in this process, PI3K inhibition could enhance the functional activity of EAP30. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA). Disruption of calcium signaling may indirectly enhance the function of EAP30 in endosomal sorting. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P operates through G-protein coupled receptors to influence endocytic trafficking and sorting. EAP30, being a part of the ESCRT-II complex, may have its functional activity enhanced through S1P's action. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may enhance EAP30's functional activity by affecting signaling pathways that regulate endocytic sorting, where EAP30 has a role. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor that could enhance EAP30 activity by inhibiting kinases that negatively regulate pathways involving the ESCRT-II complex. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore like ionomycin and can similarly increase intracellular calcium concentrations, potentially enhancing EAP30's role in vesicle formation and trafficking. | ||||||